Alemtuzumab (ALZ) as treatment for severe paraneoplastic pemphigus (PNP) associated to B-cell chronic lymphocytic leukemia (CLL)

16520 Background: ALZ is a monoclonal antibody used in the treatment of CLL. PNP is a mucocutaneous disease frequently associated with B-cell malignancies. PNP is often refractory to immunosuppress...